Ocugen (NASDAQ:OCGN) Stock Falls 50% YTD: What Next?
The possibility of marketing the coronavirus vaccine Covaxin had been one of the major triggers behind the remarkable rally that was seen in the Ocugen (NASDAQ:OCGN) stock from back in December 2020 up until November 2021. However, things have fallen apart for the company throughout the past few months. Trading Data On Friday, OCGN stock fell 0.45% to $2.23 with more than 5.20 million shares, compared to its average volume…